Study on Core Prescriptions and Drugs of TCM Against Antituberculosis Drug-Induced Liver Injury Based on Data Mining and Efficacy Screening
-
摘要:
目的 基于数据挖掘与斑马鱼模型, 分析中医药干预抗结核药物所致肝损伤(ATDILI)的用药规律, 筛选核心方药。 方法 收集相关文献, 运用中医传承辅助系统建立方剂数据库进行数据挖掘, 将核心方药在斑马鱼模型进行药效验证。 结果 筛选方剂342首, 分析得到41味常用药物, 17种常用药对, 1组核心方。核心方药干预下的ATDILI模型, 斑马鱼幼鱼的畸形率、死亡率均显著下降(P < 0.05),形态学改善,肝脏荧光面积显著上升、荧光光密度显著增强(P < 0.01)。 结论 中医药干预ATDILI以补虚、清热、利湿为总原则, 注重肝脾同治。数据挖掘得到的核心方药, 在斑马鱼ATDILI模型上均显示出一定的保肝作用, 验证了数据挖掘技术的可靠与适用。研究将数据挖掘与药理实验验证相结合,为ATDILI的治疗提供参考。 Abstract:OBJECTIVE Based on data mining and zebrafish model, to analyze the medication rules of TCM on antituberculosis drug-induced liver injury (ATDILI), and screen the core prescriptions and drugs. METHODS Literature was collected, prescriptions database was established by TCM inheritance system for data mining, and efficacy of core prescriptions and drugs were verified in zebrafish model. RESULTS A total of 342 prescriptions were screened, and 41 common drugs, 17 common drug pairs, and one core prescription were obtained. In the ATDILI model, the malformation rate and mortality rate of juvenile zebrafish were significantly reduced(P < 0.05), the morphology was improved, and the fluorescence area and intensity of liver increased significantly under the core prescriptions and drugs(P < 0.01). CONCLUSION TCM intervention in ATDILI is based on the general principle of tonifying deficiency, clearing heat and dampness, focusing on the simultaneous treatment of liver and spleen. The core prescriptions and drugs obtained from data mining showed liver protection effect in the ATDILI model of zebrafish, which verified the reliability and applicability of data mining technology. In this study, data mining and pharmacological experimental validation were combined to provide reference for the treatment of ATDILI. -
Key words:
- tuberculosis /
- hepatotoxicity /
- data mining /
- zebrafish /
- drug screening
-
表 1 高频药物
Table 1. High frequency drugs
序号 药名 频次 序号 药名 频次 1 柴胡 242 22 川芎 42 2 茯苓 170 23 百部 42 3 白芍 168 24 陈皮 41 4 炙甘草 152 25 党参 40 5 茵陈 151 26 熟地黄 39 6 丹参 147 27 生黄芪 36 7 郁金 132 28 泽泻 36 8 白术 129 29 生甘草 35 9 五味子 113 30 太子参 35 10 赤芍 103 31 制大黄 34 11 当归 99 32 枸杞子 33 12 黄芩 98 33 麦芽 31 13 枳壳 78 34 金钱草 30 14 生地黄 70 35 垂盆草 29 15 山药 64 36 牡丹皮 29 16 炙黄芪 60 37 香附 29 17 沙参 60 38 山楂 28 18 虎杖 54 39 白花蛇舌草 27 19 栀子 50 40 川楝子 27 20 麦冬 44 41 连翘 26 21 生大黄 43 表 2 支持度个数88条件下药对组合
Table 2. Drug pairs in the support degree number of 88
序号 药对 频次 序号 药对 频次 1 白芍, 柴胡 147 10 白芍, 茯苓 99 2 柴胡, 茯苓 127 11 炙甘草, 白芍, 柴胡 96 3 炙甘草, 柴胡 124 12 柴胡, 五味子 94 4 柴胡, 茵陈 122 13 白芍, 柴胡, 茯苓 92 5 丹参, 柴胡 121 14 赤芍, 柴胡 90 6 郁金, 柴胡 117 15 黄芩, 柴胡 90 7 炙甘草, 白芍 110 16 炙甘草, 茯苓 89 8 白术, 茯苓 108 17 丹参, 茵陈 88 9 白术, 柴胡 100 表 3 常用药物规则分析
Table 3. Analysis of common drug rules
序号 关联规则 置信度 1 白芍, 茯苓→柴胡 0.920 000 2 黄芩→柴胡 0.918 367 3 郁金→柴胡 0.886 364 4 白芍→柴胡 0.875 000 5 赤芍→柴胡 0.873 786 6 炙甘草, 白芍→柴胡 0.864 865 7 白术→茯苓 0.837 209 8 五味子→柴胡 0.831 858 9 丹参→柴胡 0.823 129 10 炙甘草→柴胡 0.815 789 11 茵陈→柴胡 0.807 947 表 4 核心方药对斑马鱼ATDILI模型死亡率的影响
Table 4. Effects of core prescriptions and drugs on mortality in zebrafish ATDILI models
组别 死亡率/% χ2值 组别 死亡率/% χ2值 空白对照组 0 - INH8+柴胡50 11.1** 24.171 INH8 48.6## 46.239 INH8+柴胡100 0** 46.239 INH8+DG4 0** 46.239 INH8+柴胡200 9.7** 26.353 INH8+DG20 0** 46.239 INH8+柴胡400 20.8** 12.255 INH8+DG100 0** 46.239 INH8+柴胡800 26.4** 7.585 INH8+DG500 0** 46.239 INH8+白芍50 6.9** 35.154 INH8+茯苓50 2.8** 39.610 INH8+白芍100 0** 46.239 INH8+茯苓100 2.8** 39.610 INH8+白芍200 0** 46.239 INH8+茯苓200 2.8** 39.610 INH8+白芍400 1.4** 42.815 INH8+茯苓400 1.4** 42.815 INH8+白芍800 15.3** 18.399 INH8+茯苓800 2.8** 39.610 INH8+丹参50 2.8** 39.610 INH8+炙甘草50 1.4** 42.815 INH8+丹参100 0** 46.239 INH8+炙甘草100 0** 46.239 INH8+丹参200 1.4** 42.815 INH8+炙甘草200 0** 46.239 INH8+丹参400 9.7** 26.353 INH8+炙甘草400 0** 46.239 INH8+丹参800 11.1** 24.171 INH8+炙甘草800 100.0** 18.50 INH8+白术50 1.4** 42.815 INH8+茵陈50 0** 46.239 INH8+白术100 0** 46.239 INH8+茵陈100 0** 46.239 INH8+白术200 0** 46.239 INH8+茵陈200 0** 46.239 INH8+白术400 56.9 1.003 INH8+茵陈400 1.4** 42.815 INH8+白术800 73.6** 9.468 INH8+茵陈800 2.8** 39.610 INH8+核心方50 1.4** 42.815 INH8+郁金50 2.8** 39.610 INH8+核心方100 0** 46.239 INH8+郁金100 0** 46.239 INH8+核心方200 13.9** 20.202 INH8+郁金200 0** 46.239 INH8+核心方400 27.8* 6.619 INH8+郁金400 0** 46.239 INH8+核心方800 100.0** 18.50 INH8+郁金800 6.9** 35.154 注: INH浓度单位为mmol·L-1; DG和中药水提物浓度单位为μg·mL-1;与空白组比较, ##P < 0.01;与模型组比较, **P < 0.01。 表 5 核心方药对斑马鱼ATDILI模型畸形率的影响
Table 5. Effect of core prescriptions and drugs on malformation rate in zebrafish ATDILI models
组别 畸形率/% χ2值 组别 畸形率/% χ2值 空白对照组 0 - INH8+柴胡50 65.6** 13.373 INH8 97.3## 104.601 INH8+柴胡100 63.9** 14.638 INH8+DG4 48.6** 25.511 INH8+柴胡200 75.4** 8.152 INH8+DG20 26.4** 49.159 INH8+柴胡400 89.5 1.019 INH8+DG100 27.8** 47.284 INH8+柴胡800 97.8 0 INH8+DG500 59.7** 17.299 INH8+白芍50 61.2** 16.164 INH8+茯苓50 65.7** 13.485 INH8+白芍100 27.8** 47.284 INH8+茯苓100 64.3** 14.340 INH8+白芍200 15.3** 67.036 INH8+茯苓200 64.3** 14.340 INH8+白芍400 64.8** 14.063 INH8+茯苓400 45.1** 28.451 INH8+白芍800 83.6 3.067 INH8+茯苓800 52.9** 22.051 INH8+丹参50 65.7** 13.485 INH8+炙甘草50 59.2** 17.639 INH8+丹参100 13.9** 69.708 INH8+炙甘草100 26.4** 49.159 INH8+丹参200 28.2** 46.559 INH8+炙甘草200 54.2** 21.183 INH8+丹参400 61.5** 15.874 INH8+炙甘草400 62.5** 15.503 INH8+丹参800 96.9 0 INH8+炙甘草800 - - INH8+白术50 43.7** 29.712 INH8+茵陈50 27.8** 47.284 INH8+白术100 37.5** 35.828 INH8+茵陈100 18.1** 62.019 INH8+白术200 19.4** 59.661 INH8+茵陈200 43.1** 30.360 INH8+白术400 54.8** 17.686 INH8+茵陈400 45.1** 28.451 INH8+白术800 94.7 0 INH8+茵陈800 52.9** 22.051 INH8+核心方50 18.3** 61.228 INH8+郁金50 64.3** 14.340 INH8+核心方100 11.1** 75.417 INH8+郁金100 62.5** 15.503 INH8+核心方200 77.4** 7.122 INH8+郁金200 36.1** 37.306 INH8+核心方400 98.1 0 INH8+郁金400 56.9** 19.190 INH8+核心方800 - - INH8+郁金800 71.6** 10.101 注: INH浓度单位为mmol·L-1; DG和中药水提物浓度单位为μg·mL-1;与空白组比较, ##P < 0.01;与模型组比较, **P < 0.01。 -
[1] MAHASE E. Millions of people are still missing out on TB treatment, says WHO[J]. BMJ, 2019, 367: l6097. [2] SENOUSY BE, BELAL SI, DRAGANOV PV. Hepatotoxic effects of therapies for tuberculosis[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(10): 543-556. doi: 10.1038/nrgastro.2010.134 [3] 施铮, 陈仁寿, 韩江, 等. 中药复方干预抗结核化疗致肝损伤疗效的系统评价[J]. 南京中医药大学学报, 2020, 36(1): 110-115. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202001023.htmSHI Z, CHEN RS, HAN J, et al. Systematic evaluation on the effect of Chinese medicine formula on the intervention of liver injury induced by anti-tuberculosis chemotherapy[J]. J Nanjing Univ Tradit Chin Med, 2020, 36(1): 110-115. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202001023.htm [4] WESTERF IELD M. The Zebrafish Book[M]. Eugene: University of Oregon Press, 1995. [5] 宋敏, 刘涛, 巩彦龙, 等. 基于中医传承辅助平台系统的骨质疏松症组方用药规律分析[J]. 中国骨质疏松杂志, 2017, 23(4): 519-523. doi: 10.3969/j.issn.1006-7108.2017.04.022SONG M, LIU T, GONG YL, et al. Analysis of the rule of prescription of osteoporosis based on TCM inheritance auxiliary platform system[J]. Chin J Osteoporos, 2017, 23(4): 519-523. doi: 10.3969/j.issn.1006-7108.2017.04.022 [6] HOWE K, CLARK MD, TORROJA CF, et al. The zebrafish reference genome sequence and its relationship to the human genome[J]. Nature, 2013, 496(7446): 498-503. doi: 10.1038/nature12111 [7] MCGRATH. P. Zebrafish[M]. New Jersey: John Wiley & Sons, 2012. [8] 夏青, 韩利文, 张云, 等. 基于斑马鱼模型的柴胡皂苷a保肝作用与肝毒性研究[J]. 中国中药杂志, 2019, 44(13): 2662-2666. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201913002.htmXIA Q, HAN LW, ZHANG Y, et al. Study on liver protection and hepatotoxicity of saikosaponin a based on zebrafish model[J]. China J Chin Mater Med, 2019, 44(13): 2662-2666. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201913002.htm [9] ZHANG Y, CEN J, JIA ZL, et al. Hepatotoxicity induced by isoniazid-lipopolysaccharide through endoplasmic reticulum stress, autophagy, and apoptosis pathways in zebrafish[J]. Antimicrob Agents Chemother, 2019, 63(5): e01639-e01618. [10] 马瑞娇, 贾智莉, 王学芳, 等. 基于斑马鱼模型的抗结核药物肝脏毒性比较研究[J]. 中国抗生素杂志, 2020, 45(9): 953-959. doi: 10.3969/j.issn.1001-8689.2020.09.019MA RJ, JIA ZL, WANG XF, et al. Comparative study on liver toxicity of anti-tuberculosis drugs based on the zebrafish model[J]. Chin J Antibiot, 2020, 45(9): 953-959. doi: 10.3969/j.issn.1001-8689.2020.09.019 [11] ZHANG Y, HAN LW, HE QX, et al. A rapid assessment for predicting drug-induced hepatotoxicity using zebrafish[J]. J Pharmacol Toxicol Methods, 2017, 84: 102-110. doi: 10.1016/j.vascn.2016.12.002 [12] 胡宝翠, 韦丽琴. 抗结核药物致肝损伤动物模型建立的研究进展[J]. 包头医学院学报, 2019, 35(5): 119-121, 129. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201905052.htmHU BC, WEI LQ. Research progress on the establishment of animal model of liver injury induced by anti-tuberculosis drugs[J]. J Baotou Med Coll, 2019, 35(5): 119-121, 129. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201905052.htm [13] CHOWDHURY A, SANTRA A, BHATTACHARJEE K, et al. Mitochondrial oxidative stress and permeability transition in Isoniazid and Rifampicin induced liver injury in mice[J]. J Hepatol, 2006, 45(1): 117-126. doi: 10.1016/j.jhep.2006.01.027